Synthesis of carbohydrate-based peptidomimetics as potential selective fibrinogen receptor antagonists

Letters in Peptide Science

Volumn 5, Issue 2-3, 1998, Pages 75-78

  Moitessier, Nicolas ^a   Minoux, Hervé ^a   Maigret, Bernard ^a   Chrétien, Françoise ^a   Chapleur, Yves ^a  

^a NANCY UNIVERSITÉ   (France)

Author keywords

Antagonists; D xylose scaffold; Fibrinogen receptor; Molecular modeling; Peptidomimetics

Indexed keywords

EID: 0002178419     PISSN: 09295666     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02443442     Document Type: Article

References (11)

1. Leroy, J., Potron, G., Samama, M., Guillin, M.C., Tobelem, G. and Gruel, Y. (Eds.), Hemostase et Thrombose, Edition la Simarre, Joué-les-tours, 1994.
2. Phillips, D.R., Charo, I.F. and Scarborough, R.M., Cell, 65 (1991) 359.
3. a. Kouns, W.C., Roux, S. and Steiner, B., Curr. Opin. Invest. Drugs, 2 (1993) 475.
4. b. Austel, V., Himmelsbach, F. and Müller, T., Drugs Future, 19 (1994) 757.
5. Zablocki, J.A., Nicholson, N.S. and Feigen, L.P., Exp. Opin. Invest. Drugs, 3 (1994) 437.
6. Minoux, H., Moitessier, N., Chapleur, Y. and Maigret, B., Lett. Pept. Sci., 4 (1997) 463.
7. a. Hirschmann, R., Angew. Chem. Int. Ed. Engl., 30 (1991) 1278.
8. b. Carbohydrate scaffolds have been successfully used in the synthesis of peptidomimetics: Hirschmann, R., Nicolaou, K.C., Pietranico, S., Salvino, J., Leahy, E.M., Sprengeler, P.A., Furst, G., Smith III, A.B., Strader, C.D., Cascieri, M.A., Candelore, M.R., Donaldson, C., Vale, W. and Maechler, L. J. Am. Chem. Soc., 114 (1992) 9217.
9. c. Hirschmann, R., Nicolaou, K.C., Pietranico, S., Leahy, E.M., Salvino, J., Arison, B., Cichy, M.A., Spoors, P.G., Shakespeare, W.C., Sprengeler, P.A., Hamley, P., Smith III, A.B., Reisine, T., Raynor, K., Maechler, L., Donaldson, C., Vale, W., Freidinger, R.M., Cascieri, M.R. and Strader, C.D., J. Am. Chem. Soc., 115 (1993) 12550.
10. d. Le Diguarher, T., Boudon, A., Elwell, C., Paterson, D.E. and Billington, D.C., Bioorg. Med. Chem. Lett., 6 (1996) 1983. For the use of xylofuranose scaffolds see: Papageorgiou, C., Haltiner, R., Bruns, C. and Petcher, T. J. Bioorg. Med. Chem. Lett., 2 (1992) 135.
11. d. Le Diguarher, T., Boudon, A., Elwell, C., Paterson, D.E. and Billington, D.C., Bioorg. Med. Chem. Lett., 6 (1996) 1983. For the use of xylofuranose scaffolds see: Papageorgiou, C., Haltiner, R., Bruns, C. and Petcher, T. J. Bioorg. Med. Chem. Lett., 2 (1992) 135.